MA30873B1 - Pth pegylee a titre de modulateur du recepteur de la pth et ses utilisations - Google Patents
Pth pegylee a titre de modulateur du recepteur de la pth et ses utilisationsInfo
- Publication number
- MA30873B1 MA30873B1 MA31851A MA31851A MA30873B1 MA 30873 B1 MA30873 B1 MA 30873B1 MA 31851 A MA31851 A MA 31851A MA 31851 A MA31851 A MA 31851A MA 30873 B1 MA30873 B1 MA 30873B1
- Authority
- MA
- Morocco
- Prior art keywords
- pth
- pegylee
- receptor modulator
- pth receptor
- mammal
- Prior art date
Links
- 229940075993 receptor modulator Drugs 0.000 title 1
- 206010065687 Bone loss Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82938306P | 2006-10-13 | 2006-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA30873B1 true MA30873B1 (fr) | 2009-11-02 |
Family
ID=38974655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA31851A MA30873B1 (fr) | 2006-10-13 | 2009-05-07 | Pth pegylee a titre de modulateur du recepteur de la pth et ses utilisations |
Country Status (12)
| Country | Link |
|---|---|
| AR (1) | AR063251A1 (es) |
| CL (1) | CL2007002876A1 (es) |
| CO (1) | CO6190624A2 (es) |
| CR (1) | CR10681A (es) |
| CY (1) | CY1110701T1 (es) |
| DE (1) | DE602007006839D1 (es) |
| ES (1) | ES2343917T3 (es) |
| MA (1) | MA30873B1 (es) |
| PE (1) | PE20080981A1 (es) |
| PT (1) | PT2084183E (es) |
| TW (1) | TW200817439A (es) |
| ZA (1) | ZA200901853B (es) |
-
2007
- 2007-09-11 TW TW096133901A patent/TW200817439A/zh unknown
- 2007-10-04 PT PT07843791T patent/PT2084183E/pt unknown
- 2007-10-04 ES ES07843791T patent/ES2343917T3/es active Active
- 2007-10-04 DE DE602007006839T patent/DE602007006839D1/de active Active
- 2007-10-05 CL CL200702876A patent/CL2007002876A1/es unknown
- 2007-10-11 AR ARP070104507A patent/AR063251A1/es unknown
- 2007-10-12 PE PE2007001379A patent/PE20080981A1/es not_active Application Discontinuation
-
2009
- 2009-03-16 ZA ZA200901853A patent/ZA200901853B/xx unknown
- 2009-03-20 CR CR10681A patent/CR10681A/es not_active Application Discontinuation
- 2009-04-07 CO CO09035909A patent/CO6190624A2/es not_active Application Discontinuation
- 2009-05-07 MA MA31851A patent/MA30873B1/fr unknown
-
2010
- 2010-06-18 CY CY20101100569T patent/CY1110701T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200901853B (en) | 2010-05-26 |
| CR10681A (es) | 2009-07-13 |
| AR063251A1 (es) | 2009-01-14 |
| ES2343917T3 (es) | 2010-08-12 |
| CL2007002876A1 (es) | 2008-06-06 |
| CO6190624A2 (es) | 2010-08-19 |
| CY1110701T1 (el) | 2015-06-10 |
| PT2084183E (pt) | 2010-07-16 |
| TW200817439A (en) | 2008-04-16 |
| PE20080981A1 (es) | 2008-07-19 |
| DE602007006839D1 (de) | 2010-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022009942A (es) | Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo. | |
| TNSN07005A1 (fr) | Analogues tetrapeptidiques | |
| EA200870424A1 (ru) | Способы применения рецептора gpr119 для идентификации соединений, которые можно использовать для увеличения костной массы субъекта | |
| MA28436B1 (fr) | Modulateurs selectifs du recepteur des oestrogenes pour le traitement de symptômes vasomoteurs | |
| MX2011013467A (es) | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). | |
| PH12015500301B1 (en) | A novel formulation of diclofenac | |
| MA32226B1 (fr) | Compositions et leurs procedes de preparation et d'utilisation | |
| MA33044B1 (fr) | Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient | |
| EA200900203A1 (ru) | Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение | |
| MA35455B1 (fr) | (wo2013045407) dérivés d'estra-1,3,5(10),16-tétraène-3-carboxamide, procédé pour leur fabrication, préparations pharmaceutiques contenant ces substances ainsi que leur utilisation dans la fabrication de médicaments | |
| MA33299B1 (fr) | Nouvelle formulation de naproxène | |
| MA33419B1 (fr) | Composés et compositions pour le traitement de maladies parasitaires | |
| MX2009005114A (es) | Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus. | |
| MX2011012015A (es) | Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer. | |
| UA94922C2 (ru) | Способ регулирования специфичности сигнализации тканевого фактора у млекопитающего, которое нуждается в этом, способ идентификации агента, который специфически ингибирует сигнализацию тканевого фактора | |
| WO2008088771A3 (en) | Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens | |
| MX2009005245A (es) | Metodo de tratamiento para la enfermedad intestinal inflamatoria. | |
| PL379512A1 (pl) | Nowe metody i ich zastosowanie | |
| WO2007147868A3 (en) | Prevention of muscle atrophy | |
| MA30873B1 (fr) | Pth pegylee a titre de modulateur du recepteur de la pth et ses utilisations | |
| MX2009003740A (es) | Pth pegilado como moduladores de receptor pth y usos de los mismos. | |
| BR0308517A (pt) | Combinação de um antagonista do receptor de aldosterona e de um agente sequestrante de ácido biliar | |
| TNSN08497A1 (fr) | Composition nasale et buccale pour lutter contre le ronflement | |
| MX2007008417A (es) | Forma de dosificacion para tratar desordenes gastrointestinales. | |
| CO6150137A2 (es) | Composicion farmaceutica que contiene bicalutamida y un metodo para su uso |